Experimental results have revealed that a combination of PGC-1β downregulation and FOXA2 overexpression notably restrained the activity of breast cancer cells through the regulation of the PI3K-AKT-mTOR pathway [32,110]. The gene discussed is FOXA2; the disease is breast cancer.